Invivyd (IVVD) Operating Expenses (2021 - 2025)
Invivyd (IVVD) reported Operating Expenses of $29.8 million for Q4 2025, down 9.95% on a YoY basis from $33.0 million in Q4 2024, and up 23.23% quarter-over-quarter from $24.2 million in Q3 2025.
Invivyd (IVVD) Operating Expenses (2021 - 2025) Analysis & Trends
Invivyd has reported Operating Expenses for 5 years, with the latest figure at $29.8 million in Q4 2025.
- For the quarter ending Q4 2025, Operating Expenses fell 9.95% year-over-year to $29.8 million; the trailing twelve-month figure through Dec 2025 stood at $109.0 million (down 46.12% YoY), and the FY2025 full-year result was $109.0 million, down 46.12% from the prior year.
- Operating Expenses for Q4 2025 stood at $29.8 million, up from $24.2 million in the prior quarter.
- The five-year high for Operating Expenses was $100.7 million in Q1 2022, with the low at $24.2 million in Q3 2025.
- Historically, Operating Expenses has averaged $49.9 million across 5 years, with a median of $46.7 million in 2022.
- Annual changes were most pronounced in 2022 — Operating Expenses soared 160.25% — and 2025, when it slumped 66.27%.
- Invivyd's Operating Expenses stood at $83.1 million in 2021, then plunged by 41.98% to $48.2 million in 2022, then surged by 59.2% to $76.8 million in 2023, then plunged by 56.94% to $33.0 million in 2024, then dropped by 9.95% to $29.8 million in 2025.
- The last three Operating Expenses figures came in at $29.8 million (Q4 2025), $24.2 million (Q3 2025), and $26.8 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 4.33 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 32.68 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -138.30 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.82 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 15.76 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 574,669.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.85 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -67.40 Mn |
| 10 | Invivyd | 168.41 Mn | -58.28 Mn | - | 29.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 29.76 Mn |
| Sep 30, 2025 | 24.15 Mn |
| Jun 30, 2025 | 26.85 Mn |
| Mar 31, 2025 | 28.23 Mn |
| Dec 31, 2024 | 33.05 Mn |
| Sep 30, 2024 | 71.61 Mn |
| Jun 30, 2024 | 51.51 Mn |
| Mar 31, 2024 | 46.09 Mn |
| Dec 31, 2023 | 76.75 Mn |
| Sep 30, 2023 | 43.06 Mn |
| Jun 30, 2023 | 53.88 Mn |
| Mar 31, 2023 | 39.07 Mn |
| Dec 31, 2022 | 48.21 Mn |
| Sep 30, 2022 | 47.33 Mn |
| Jun 30, 2022 | 51.75 Mn |
| Mar 31, 2022 | 100.74 Mn |
| Dec 31, 2021 | 83.09 Mn |
| Sep 30, 2021 | 60.42 Mn |
| Jun 30, 2021 | 44.69 Mn |
| Mar 31, 2021 | 38.71 Mn |